Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Browse the world's most comprehensive archive of hedge fund manager letters. Access primary source research from leading institutional managers, sorted by reporting period.
The fund returned 30% year-to-date as the Strait of Hormuz closure disrupted 14 million barrels per day for four months. Despite this, energy equities underperformed global markets and major oil stocks declined. Managers see 20% further upside as valuations imply only $73/bl long-term Brent versus their $80/bl target. Inventories approach critical minimums by September if disruption continues, forcing sharp price increases.
Full Quick Take
The fund returned 30% year-to-date as the Strait of Hormuz closure disrupted 14 million barrels per day for four months. Despite this, energy equities underperformed global markets and major oil stocks declined. Managers see 20% further upside as valuations imply only $73/bl long-term Brent versus their $80/bl target. Inventories approach critical minimums by September if disruption continues, forcing sharp price increases.
Akre Focus Fund underperformed the S&P 500 this quarter (6.46% vs 10.94%) but remains committed to high-quality compounding businesses over cheap 'value' bounces, raising its cash position to 8.1% and preparing to transition into an ETF structure.
Full Quick Take
Akre Focus Fund underperformed the S&P 500 this quarter (6.46% vs 10.94%) but remains committed to high-quality compounding businesses over cheap 'value' bounces, raising its cash position to 8.1% and preparing to transition into an ETF structure.
Brown Advisory exploited macro tariff shocks to buy high-quality compounders like Experian and topped up key AI winners, while rigorously enforcing discipline to exit deteriorating healthcare holdings.
Full Quick Take
Brown Advisory exploited macro tariff shocks to buy high-quality compounders like Experian and topped up key AI winners, while rigorously enforcing discipline to exit deteriorating healthcare holdings.
